Terapia medicamentosa no programa de cessação do tabagismo no Brasil e no mundo: revisão de literatura

Abstract

Smoking is a disease caused by nicotine addiction, and to avoid harming, they instituted National Tobacco Control Program. One of its actions involves treatment for smoking cessation through therapeutic counselling and pharmacological support, such as Nicotine Replacement Therapy and Bupropion, provided by the Unified Health System. This study aims to identify how the treatment has been for people inserted in the Smoking Cessation Program. It is an integrative literature review of selected articles in the databases: Virtual Health Library and Pubmed, from 2015 to 2020, in Portuguese, English and Spanish. The descriptors were: Smoking and drug treatment. The research selected seven articles to become part of the review through a selection resulting from an adaptation of the PRISMA protocol. The results show that treatment with varenicline, behavioural counselling and gradually reducing the number of cigarettes increases smoking cessation rates. Other promising therapies such as Yoga, micronutrients and psilocybin still need further study. This theme is of great interest to Public Health, and we hope these findings can improve the Program and instigate further research.